Evidence map›Paper›PMID 41634348›Full record

ArticleNPJ precision oncology2026

Noninvasive prediction of occult pT3a upstaging in localized ccRCC with radiogenomic insights and prognostic relevance.

Shichao Li, Chuhuai Wang, Feng Li, Mengmeng Gao, Kangwen He, Ziling Zhou, Weinuo Qu, Yaqi Shen, Qian Chu, Shan Wu and 3 more

Abstract read
In one paragraph

Article in NPJ precision oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shichao Li *Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Chuhuai Wang *MOE Key Laboratory for Biomedical Photonics, Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan, China.
Feng Li *Department of Radiology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China.
Mengmeng GaoDepartment of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Kangwen HeDepartment of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ziling ZhouDepartment of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Weinuo QuDepartment of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yaqi ShenDepartment of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Qian ChuDepartment of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Shan WuShanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, China. wushan@sxbqeh.com.cn.
Jinrong QuDepartment of Radiology, the Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China. qjryq@126.com.
Yudong ZhangDepartment of Radiology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China. zhangyd3895@njmu.edu.cn.
Zhen LiDepartment of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. zhenli@hust.edu.cn.

Funding

Local Science and Technology Development Fund Project Guided by Central Government of China YDZJSX 2025D074National Natural Science Foundation of China 62131009National Natural Science Foundation of China 82371942National Natural Science Foundation of China 82502331Xiangyang Science and Technology Program in Healthcare Field 2022YL19A
6 · The paper itself

Abstract

Occult pathological T3a (pT3a) upstaging in cT1b-T2a clear cell renal cell carcinoma (ccRCC) correlated with poor prognosis and necessitated modifications in surgical planning. However, predicting it preoperatively remains challenging. In this multicenter study involving 1661 patients across five institutions and the KiTS23 dataset, RENALNet, a 3D deep learning framework trained on nephrographic-phase CT, was developed and validated. RENALNet outperformed radiomics models, further enhancing diagnostic accuracy when combined with radiologists of varying experience. Grad-CAM visualizations concentrated on anatomically significant invasion sites, improving interpretability. Risk scores derived from RENALNet were found to correlate with Ki-67 proliferation indices and effectively stratified 5-year progression-free survival, demonstrating both biological and prognostic relevance. Transcriptomic analysis revealed that high RENALNet risk was associated with gene expression signatures enriched in pathways such as epithelial-mesenchymal transition, IL6-JAK-STAT3 signaling, and PI3K-Akt signaling, highlighting its link to tumor aggressiveness. RENALNet thus offers a biologically interpretable framework for risk stratification in ccRCC, supporting surgical decision-making and advancing the integration of radiogenomic deep learning into precision oncology.

Identifiers

PMID41634348
PMCPMC12976368

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.